Mark Baker - Concepedia

Author

Mark Baker

Also Known As

Baker Mark, Baker, Mark, Christopher Baltus, J Phillips, Jeffrey Boats, M. Baker, Mark Baker, Mark Baker (661189), Mark D. Baker, Pierre Hugo

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Medicines for Malaria Venture QIMR Berghofer Medical Research Institute The University of Queensland Mater Health Services University of Oxford

About

Mark Baker is an author at Medicines for Malaria Venture specializing in medicine, pharmacology, and malaria.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	552
2	Biochemistry	3	3	496
3	Health Sciences	1	1	56
4	Natural Sciences	1	1	441
5	Epidemiology	1	1	56

Mark Baker

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Wesley C. Van Voorhis, John H. Adams, Roberto Adelfio, PLoS Pathogens Drug TargetBioorganic ChemistryAntiparasitic AgentMalariaMedicinal Chemistry	2016	441
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis Amy Cutrell, Jonathan Schapiro, Carlo Federico Perno, AIDS	2021	189
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial Aung Pyae Phyo, Podjanee Jittamala, François Nosten, The Lancet Infectious Diseases	2015	187
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study Alejandro Llanos‐Cuentas, Martín Casapía, Raúl Chuquiyauri, The Lancet Infectious Diseases	2018	139
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study James McCarthy, Thomas Rückle, Elhadj Djeriou, Malaria Journal	2016	125
Efficacy of OZ439 (artefenomel) against early <i>Plasmodium falciparum</i> blood-stage malaria infection in healthy volunteers James McCarthy, Mark Baker, Peter O’Rourke, Journal of Antimicrobial Chemotherapy	2016	102
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis Lucy Okell, Matthew Cairns, Jamie T. Griffin, Nature Communications	2014	99
Piperaquine Monotherapy of Drug-Susceptible<i>Plasmodium falciparum</i>Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia Cielo Pasay, Rebecca J. Rockett, Silvana Sekuloski, The Journal of Infectious Diseases	2016	67
Evaluating the Pharmacodynamic Effect of Antimalarial Drugs in Clinical Trials by Quantitative PCR Louise Marquart, Mark Baker, Peter O’Rourke, Antimicrobial Agents and Chemotherapy Antiparasitic AgentMalariaPharmacotherapyQuantitative PcrPharmacodynamic Modeling	2015	56
Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects Kelong Han, Mark Baker, Mark Lovern, British Journal of Clinical Pharmacology	2022	51

Page 1